Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InterMedical Care and Lab Hospital PCL has the GF Score of 58, which implies that the company
might have
Poor future performance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
InterMedical Care and Lab Hospital PCL (BKK:IMH) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
InterMedical Care and Lab Hospital PCL GF Score Related Terms
BKK:IMH vs HCA, THC, DVA: GF Score Comparison
For the Medical Care Facilities subindustry, InterMedical Care and Lab Hospital PCL's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InterMedical Care and Lab Hospital PCL GF Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, InterMedical Care and Lab Hospital PCL's GF Score distribution charts can be found below:
* The bar in red indicates where InterMedical Care and Lab Hospital PCL's GF Score falls into.
InterMedical Care and Lab Hospital PCL (BKK:IMH) has a GF Score of 58 as of Jul. 15, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on InterMedical Care and Lab Hospital PCL and its competitors. This is near median its historical median of 58.00. Over the past decade, InterMedical Care and Lab Hospital PCL's GF Score has ranged from 15.00 to 86.00.
Is InterMedical Care and Lab Hospital PCL's GF Score too high?
InterMedical Care and Lab Hospital PCL's current GF Score of 58 is near median its 10-year median of 58.00. Over the past 10 years, this metric has ranged from a low of 15.00 to a high of 86.00. Overall, InterMedical Care and Lab Hospital PCL has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does InterMedical Care and Lab Hospital PCL's GF Score compare to HCA and THC?
InterMedical Care and Lab Hospital PCL's GF Score of 58 can be compared against companies in the Healthcare Providers & Services industry. Historically, InterMedical Care and Lab Hospital PCL's own GF Score has ranged from 15.00 to 86.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Healthcare Providers & Services company?
A good GF Score depends on the Healthcare Providers & Services industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on InterMedical Care and Lab Hospital PCL and its competitors. InterMedical Care and Lab Hospital PCL's current GF Score is 58, which is near median its own 10-year median of 58.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InterMedical Care and Lab Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL (BKK:IMH) is currently considered Possible Value Trap. The stock's GF Value™ is ฿4.43, compared to a current price of ฿3.06 — trading 30.9% below its estimated fair value. The current GF Score is 58, which is near median its 10-year median of 58.00. InterMedical Care and Lab Hospital PCL's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For InterMedical Care and Lab Hospital PCL (BKK:IMH), the current GF Score is 58 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InterMedical Care and Lab Hospital PCL (BKK:IMH) Overvalued in 2026?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL stock appears to be undervalued.
The current stock price of ฿3.06 is trading 30.9% below its estimated GF Value™ of ฿4.43.
GuruFocus considers InterMedical Care and Lab Hospital PCL to be Possible Value Trap.
Key valuation signals for BKK:IMH:
GF Score: 58 (near median its 10-year median of 58.00)
GF Value™: ฿4.43 vs. price of ฿3.06 (30.9% below fair value)
No single metric tells the full story. See the BKK:IMH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InterMedical Care and Lab Hospital PCL Business Description
InterMedical Care and Lab Hospital PCL is a company principally engaged in specialty medical hospitals, and occupational medicine. The business segments of the firm are Prachapat hospital, Occupational Medicine hospital and Environmental Analysis. Prachapat Hospital is engaged in rendering medical services to patients under government welfare schemes. Occupational Medicine Hospital is engaged in providing physical examination services. Majority of revenue is from Hospital Segment. Geographically, the company operates in Thailand.
58GF Score
Get the complete analysis for BKK:IMH
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:IMH has been successfully added to your 
